Outcomes4Me Acquires Geno.Me and Realyze Intelligence, Names UPMC Hillman Cancer Center CIO as Strategic Advisor, to Expedite AI-driven Cancer Care and Clinical Trial Access

BOSTON, May 21, 2026 /PRNewswire/ -- Outcomes4Me Inc., the leading direct-to-patient health technology company leveraging AI to revolutionize cancer care, today announced it has completed its acquisitions of two innovative platforms: Geno.Me, a platform that bridges the gap between...